Search

Roche Holding AG

Open

SectorGezondheidszorg

278.6 -0.14

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

273.4

Max

280

Belangrijke statistieken

By Trading Economics

Inkomsten

6.3B

Verkoop

31B

K/W

Sectorgemiddelde

26.169

57.333

Dividendrendement

3.6

Winstmarge

20.347

Werknemers

103,249

EBITDA

11B

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

3.60%

2.63%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

205B

Vorige openingsprijs

278.74

Vorige sluitingsprijs

278.6

Roche Holding AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 apr 2025, 07:30 UTC

Winsten

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 apr 2025, 05:31 UTC

Winsten

Roche Sales Rise Boosted By Key Drugs

9 apr 2025, 09:39 UTC

Belangrijke Marktbewegers

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

12 mrt 2025, 09:23 UTC

Belangrijke Marktbewegers

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30 jan 2025, 09:36 UTC

Winsten

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30 jan 2025, 06:32 UTC

Winsten

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

24 apr 2025, 09:39 UTC

Marktinformatie
Winsten

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 apr 2025, 09:24 UTC

Marktinformatie
Winsten

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 apr 2025, 09:18 UTC

Marktinformatie
Winsten

Roche's Results Are Solid -- Market Talk

24 apr 2025, 05:16 UTC

Top Nieuws

Roche Sales Rise, Boosted By Key Drugs

22 apr 2025, 10:51 UTC

Top Nieuws

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15 apr 2025, 09:55 UTC

Marktinformatie

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 apr 2025, 10:03 UTC

Marktinformatie
Winsten

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

9 apr 2025, 07:23 UTC

Marktinformatie

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 apr 2025, 08:41 UTC

Marktinformatie

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 apr 2025, 07:51 UTC

Marktinformatie

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

31 mrt 2025, 09:31 UTC

Populaire aandelen

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13 mrt 2025, 07:46 UTC

Marktinformatie

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12 mrt 2025, 16:34 UTC

Top Nieuws

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12 mrt 2025, 08:51 UTC

Marktinformatie

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12 mrt 2025, 08:18 UTC

Marktinformatie

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13 feb 2025, 11:43 UTC

Marktinformatie

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30 jan 2025, 07:56 UTC

Marktinformatie
Winsten

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30 jan 2025, 06:04 UTC

Winsten

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

30 jan 2025, 06:04 UTC

Winsten

Roche Expects 2025 Sales Increase in Mid Single Digit Range at Constant Currency

30 jan 2025, 06:04 UTC

Winsten

Roche Issues 2025 View

30 jan 2025, 06:03 UTC

Winsten

Roche Raises Dividend to CHF9.70 Vs CHF9.60

30 jan 2025, 06:03 UTC

Winsten

Roche 2024 Core Operating Profit CHF20.82B

30 jan 2025, 06:03 UTC

Winsten

Roche 2024 Net Pft CHF9.19B

30 jan 2025, 06:02 UTC

Winsten

Analysts Saw 2024 Core EPS at CHF18.59

Roche Holding AG Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.